Bacillus subtilis spores reduce susceptibility to Citrobacter rodentium-mediated enteropathy in a mouse model

Research in Microbiology

Volumn 157, Issue 9, 2006, Pages 891-897

  D'Arienzo, Rossana ^a   Maurano, Francesco ^a   Mazzarella, Giuseppe ^a   Luongo, Diomira ^a   Stefanile, Rosita ^a   Ricca, Ezio ^b   Rossi, Mauro ^a  

^a CNR   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Bacillus subtilis; Citrobacter rodentium; Enteropathy; Mesenteric lymph nodes; Mucosal immunity; Spores

Indexed keywords

GAMMA INTERFERON; MESSENGER RNA; PROBIOTIC AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACILLUS SUBTILIS; BACTERIAL COLONIZATION; BACTERIAL SPORE; BACTERIAL TRANSMISSION; CD4 LYMPHOCYTE COUNT; CITROBACTER RODENTIUM; CONTROLLED STUDY; DESCENDING COLON; DISEASE PREDISPOSITION; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ENTEROPATHOGENIC ESCHERICHIA COLI; ENTEROPATHY; GASTROINTESTINAL INFECTION; HOST SUSCEPTIBILITY; HYPERPLASIA; IMMUNE RESPONSE; IMMUNOHISTOLOGY; INTESTINE INFECTION; LIVER; MESENTERY LYMPH NODE; MORPHOLOGY; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA ANALYSIS;

ANIMALS; ANTIGENS, CD4; BACILLUS SUBTILIS; CITROBACTER RODENTIUM; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; INTERFERON TYPE II; INTERFERON-GAMMA; INTESTINAL DISEASES; MICE; SPORES, BACTERIAL;

ANIMALIA; BACILLUS SUBTILIS; CITROBACTER RODENTIUM; ESCHERICHIA COLI;

EID: 33749650749     PISSN: 09232508     EISSN: 17697123     Source Type: Journal    
DOI: 10.1016/j.resmic.2006.06.001     Document Type: Article

References (41)

1. Barbosa T.M., Serra C.R., La Ragione R.M., Woodward M.J., and Henriques A.O. Screening for Bacillus isolates in the broiler gastrointestinal tract. Appl. Environ. Microbiol. 71 (2005) 968-978
2. Barthold S.W., Osbaldiston G.W., and Jonas A.M. Dietary, bacterial, and host genetic interactions in the pathogenesis of transmissible murine colonic hyperplasia. Lab. Anim. Sci. 27 (1977) 938-945
3. Barthold S.W., Coleman G.L., Jacoby R.O., Livestone E.M., and Jonas A.M. Transmissible murine colonic hyperplasia. Vet. Pathol. 15 (1978) 223-236
4. Casula G., and Cutting S.M. Bacillus probiotics: Spore germination in the gastrointestinal tract. Appl. Environ. Microbiol. 68 (2002) 2344-2352
5. Chen H.D., and Frankel G. Enteropathogenic Escherichia coli: Unravelling pathogenesis. FEMS Microbiol. Rev. 29 (2005) 83-98
6. Chomczynski P., and Sacchi N. Single-step method isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162 (1987) 156-159
7. Cutting S., and Vander Horn P.B. Genetic analysis. In: Harwood C., and Cutting S. (Eds). Molecular Biological Methods for Bacillus (1990), Wiley, Chichester, UK 27-74
8. Czerucka D., Dahan S., Mograbi B., Rossi B., and Rampal P. P. Saccharomyces boulardii preserves the barrier function and modulates the signal transduction pathway induced in enteropathogenic Escherichia coli-infected T84 cells. Infect. Immun. 68 (2000) 5998-6004
9. Czerucka D., and Rampal P. Experimental effects of Saccharomyces boulardii on diarrheal pathogens. Microbes Infect. 4 (2002) 733-739
10. Donnenberg M.S., Tzipori S., McKee M.L., O'Brien A.D., Alroy J., and Kaper J.B. The role of the eae gene of enterohemorrhagic Escherichia coli in intimate attachment in vitro and in a porcine model. J. Clin. Invest. 92 (1993) 1418-1424
11. Duc L.H., Hong H.A., and Cutting S.M. Germination of the spore in the gastrointestinal tract provides a novel route for heterologous antigen delivery. Vaccine 21 (2003) 4215-4224
12. Duc L.H., Hong H.A., Uyen N.Q., and Cutting S.M. Intracellular fate and immunogenicity of B. subtilis spores. Vaccine 22 (2004) 1873-1885
13. Duc L.H., Hong H.A., Barbosa T.M., Henriques A.O., and Cutting S.M. Characterization of Bacillus probiotics available for human use. Appl. Environ. Microbiol. 70 (2004) 2161-2171
14. Falk P.G., Hooper L.V., Midvedt T., and Gordon J.I. Creating and maintaining the gastrointestinal ecosystem: What we know add need to know for gnotobiology. Microbiol. Mol. Biol. Rev. 62 (1998) 1157-1170
15. Hamilton-Miller J.M. The role of probiotics in the treatment and prevention of Helicobacter pylori infection. Int. J. Antimicrob. Agents 22 (2003) 360-366
16. Higgins L.M., Frankel G., Douce G., Dougan G., and MacDonald T.T. Citrobacter rodentium infection in mice elicits a mucosal Th1 cytokine response and lesions similar to those in murine inflammatory bowel disease. Infect. Immun. 67 (1999) 3031-3039
17. Hoa T.T., Duc L.H., Isticato R., Baccigalupi L., Ricca E., Van P.H., and Cutting S.M. Fate and dissemination of Bacillus subtilis spores in a murine model. Appl. Environ. Microbiol. 67 (2001) 3819-3823
18. Hong H.A., Duc L.H., and Cutting S.M. The use of bacterial spore formers as probiotics. FEMS Microbiol. Rev. 29 (2005) 813-835
19. Hooper L.V., Bry L., Falk P.G., and Gordon J.I. Host-microbial symbiosis in the mammalian intestine: Exploring an internal ecosystem. Bioessays 20 (1998) 336-343
20. Itoh K., Maejima K., Ueda K., and Fujiwara K. Effect of intestinal flora on megaenteron of mice. Microbiol. Immunol. 22 (1978) 661-672
21. Itoh K., Ueda K., and Fujiwara K. Susceptibility of germ-free mice to infectious megaenteron. Microbiol. Immunol. 24 (1980) 281-290
22. Itoh K., Matsui T., Tsuji K., Mitsuoka T., and Ueda K. Genetic control in the susceptibility of germfree inbred mice to infection by Escherichia coli O115a,c:K(B). Infect. Immun. 56 (1988) 930-935
23. Johnson-Henry K.C., Nadjafi M., Avitzur Y., Mitchell D.J., Ngan B.Y., Galindo-Mata E., Jones N.L., and Sherman P.M. Amelioration of the effects of Citrobacter rodentium infection in mice by pretreatment with probiotics. J. Infect. Dis. 191 (2005) 2106-2117
24. Kuhn R., Lohler J., Rennick D., Rajewsky K., and Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75 (1993) 263-274
25. La Ragione R.M., and Woodward M.J. Competitive exclusion by Bacillus subtilis spores of Salmonella enterica serotype Enteritidis and Clostridium perfringens in young chickens. Vet. Microbiol. 94 (2003) 245-256
26. Lee Y.K., and Salminen S. The coming age of probiotics. Trends Food Sci. Technol. 6 (1995) 241-245
27. Maggio-Price L., Nicholson K.L., Kline K.M., Birkebak T., Suzuki I., Wilson D.L., Schauer D D., and Fink P.J. Diminished reproduction, failure to thrive, and altered immunologic function in a colony of T-cell receptor transgenic mice: Possible role of Citrobacter rodentium. Lab. Anim. Sci. 48 (1998) 145-155
28. Nicholson W.L., and Setlow P. Sporulation, germination and outgrowth. In: Harwood C., and Cutting S. (Eds). Molecular Biological Methods for Bacillus (1990), Wiley, Chichester, UK 391-450
29. Nurmi E., and Rantala M. New aspects of Salmonella infection in broiler production. Nature 241 (1973) 210-211
30. Resta-Lenert S., and Barrett K.E. Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut 52 (2003) 988-997
31. Rothbaum R.J., Partin J.C., Saalfield K., and McAdams A.J. An ultrastructural study of enteropathogenic Escherichia coli infection in human infants. Ultrastruct. Pathol. 4 (1983) 291-304
32. Schauer D.B., and Falkow S. Attaching and effacing locus of a Citrobacter freundii biotype that causes transmissible murine colonic hyperplasia. Infect. Immun. 61 (1993) 2486-2492
33. Schauer D.B., and Falkow S. The eae gene of Citrobacter freundii biotype 4280 is necessary for colonization in transmissible murine colonic hyperplasia. Infect. Immun. 61 (1993) 4654-4661
34. Schauer D.B., Zabel B.A., Pedraza I.F., O'Hara C.M., Steigerwalt A.G., and Brenner D.J. Genetic and biochemical characterization of Citrobacter rodentium sp. nov. J. Clin. Microbiol. 33 (1995) 2064-2068
35. Senesi S. Bacillus spores as probiotic products for human use. In: Ricca E., Henriques A.O., and Cutting S.M. (Eds). Bacterial Spore Formers (2004), Horizon Bioscience, Norfolk, UK 131-141
36. Senger S., Luongo D., Maurano F., Mazzeo F.M., Siciliano R.A., Gianfrani C., David C., Troncone R., Auricchio S., and Rossi M. Intranasal administration of a recombinant alpha-gliadin down-regulates the immune response to wheat gliadin in DQ8 transgenic mice. Immunol. Lett. 88 (2003) 127-134
37. + T cells in immunity to infection by the attaching and effacing pathogen Citrobacter rodentium. Infect. Immun. 71 (2003) 5077-5086
38. Tam N.K., Uyen N.Q., Hong H.A., Duc le H., Hoa T.T., Serra C.R., Henriques A.O., and Cutting S.M. The intestinal life cycle of Bacillus subtilis and close relatives. J. Bacteriol. 188 (2006) 2692-2700
39. Watanabe M., Ueno Y., Yajima T., Okamoto S., Hayashi T., Yamazaki M., Iwao Y., Ishii H., Habu S., Uehira M., Nishimoto H., Ishikawa H., Hata J., and Hibi T. Interleukin 7 transgenic mice develop chronic colitis with decreased interleukin 7 protein accumulation in the colonic mucosa. J. Exp. Med. 187 (1998) 389-402
40. Wiles S., Clare S., Harker J., Huett A., Young D., Dougan G., and Frankel G. Organ specificity, colonization and clearance dynamics in vivo following oral challenges with the murine pathogen Citrobacter rodentium. Cell. Microbiol. 6 (2004) 963-972
41. Youngman P., Perkins J.B., and Losick R. A novel method for the rapid cloning in Escherichia coli of Bacillus subtilis chromosomal DNA adjacent to Tn917 insertion. Mol. Gen. Genet. 195 (1984) 424-433